NanoSyrinx

About NanoSyrinx

NanoSyrinx is a discovery-stage biotechnology company based in the United Kingdom that is developing a next-generation platform for intracellular delivery of biologics. Leveraging synthetic biology, the company aims to create protein nanosyringes to enable targeted delivery of protein and peptide therapeutics inside cells, addressing drugs that struggle to reach intracellular targets. Built on a decade of research, NanoSyrinx focuses on transforming intracellular bioavailability and tackling historically undruggable intracellular targets. The company highlights its headquarters and corporate activities in Coventry, UK, and communicates progress through a corporate deck and news updates.